http://ipn.intelihealth.com/ipn/ihtIPN?c=207988
Caspase Inhibitors Improve Survival Of Transplants Used To Treat Rat
Model Of
Parkinson's
WESTPORT, Jan 19 (Reuters Health) - A synthetic
peptide inhibitor of the caspase family of
proteases
reduces apoptosis and improves the survival of
embryonic nigral cell transplants used to treat a
rat
model of Parkinson's disease, according to findings
of a
European study published in the January issue of
Nature Medicine.
--
Kathrynne Holden, MS, RD
"Nutrition you can live with!"
Medical nutrition therapy
http://www.nutritionucanlivewith.com/
Tel: 970-493-6532 // Fax: 970-493-6538
"If we knew what it was we were doing,
it would not be called research,
would it?" -Albert Einstein
